{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T22:37:57Z","timestamp":1777934277641,"version":"3.51.4"},"reference-count":11,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[2017,3,29]],"date-time":"2017-03-29T00:00:00Z","timestamp":1490745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Oncol Pharm Pract"],"published-print":{"date-parts":[[2018,7]]},"abstract":"<jats:p>Pembrolizumab, a selective anti-PD-1 humanized monoclonal antibody, reactivates T cells to fight cancer. Immune-related adverse events such as autoimmune colitis, pneumonitis, hepatitis, nephritis, hypophysitis, and thyroiditis may occur during, or weeks to months after therapy. Pemprolizumab-induced synovitis is rarely reported. With the wide use of immunotherapy to treat cancers, physicians need to be aware of this rare immune-related adverse event and provide immediate treatment to avoid permanent joint damage.<\/jats:p>","DOI":"10.1177\/1078155217701292","type":"journal-article","created":{"date-parts":[[2017,3,30]],"date-time":"2017-03-30T01:40:46Z","timestamp":1490838046000},"page":"389-392","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":6,"title":["Could knee inflammatory synovitis be induced by pembrolizumab?"],"prefix":"10.1177","volume":"24","author":[{"given":"Fade","family":"Mahmoud","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Division of Hematology\/Oncology, University of Arkansas for Medical Sciences, Little Rock, AR, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John T","family":"Wilkinson","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, University of Arkansas for Medical Sciences, Little Rock, AR, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"Gizinski","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, University of Arkansas for Medical Sciences, Little Rock, AR, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjaya","family":"Viswamitra","sequence":"additional","affiliation":[{"name":"Department of Radiology, University of Arkansas for Medical Sciences, Little Rock, AR, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neriman","family":"Gokden","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Vander Schilden","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, University of Arkansas for Medical Sciences, Little Rock, AR, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2017,3,29]]},"reference":[{"key":"bibr1-1078155217701292","doi-asserted-by":"publisher","DOI":"10.1177\/1078155215627503"},{"key":"bibr2-1078155217701292","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60958-2"},{"key":"bibr3-1078155217701292","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1200690"},{"key":"bibr4-1078155217701292","doi-asserted-by":"publisher","DOI":"10.1097\/CJI.0000000000000060"},{"key":"bibr5-1078155217701292","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2016.03.003"},{"key":"bibr6-1078155217701292","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209595"},{"key":"bibr7-1078155217701292","doi-asserted-by":"publisher","DOI":"10.1097\/CJI.0b013e318247a4e7"},{"key":"bibr8-1078155217701292","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.021908.132710"},{"key":"bibr9-1078155217701292","doi-asserted-by":"publisher","DOI":"10.1002\/art.27622"},{"key":"bibr10-1078155217701292","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.4049\/jimmunol.160.7.3513","volume":"160","author":"Jovanovic DV","year":"1998","journal-title":"J Immunol"},{"key":"bibr11-1078155217701292","doi-asserted-by":"publisher","DOI":"10.1084\/jem.183.6.2593"}],"container-title":["Journal of Oncology Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1078155217701292","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1078155217701292","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1078155217701292","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T02:17:16Z","timestamp":1777688236000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1078155217701292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,29]]},"references-count":11,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["10.1177\/1078155217701292"],"URL":"https:\/\/doi.org\/10.1177\/1078155217701292","relation":{},"ISSN":["1078-1552","1477-092X"],"issn-type":[{"value":"1078-1552","type":"print"},{"value":"1477-092X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,29]]}}}